DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	sulfachlorpyridazine	6634	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	sulfachlorpyridazine	6634	drug-path
Asthma	R-HSA-444620	map05310	sulfachlorpyridazine	6634	drug-path
Allograft rejection	R-HSA-9679028	map05330	sulfachlorpyridazine	6634	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	sulfachlorpyridazine	6634	drug-path
Glioma	Q9NZM4	map05214	sulfachlorpyridazine	6634	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	sulfachlorpyridazine	6634	drug-path
Olfactory transduction	R-HSA-9751605	map04740	citalopram	2771	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	citalopram	2771	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	citalopram	2771	drug-path
VEGF signaling pathway	R-HSA-194138	map04370	citalopram	2771	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	withaferin A	6076	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	withaferin A	6076	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	withaferin A	6076	drug-path
Huntington's disease	R-HSA-1643685	0	withaferin A	6076	drug-path
Olfactory transduction	R-HSA-9751605	map04740	withaferin A	6076	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	withaferin A	6076	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	withaferin A	6076	drug-path
Bladder cancer	R-HSA-9700206	map05219	withaferin A	6076	drug-path
p53 signaling pathway	R-HSA-168638	map04115	withaferin A	6076	drug-path